Explore our comprehensive coverage of health economics, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The convergence of CMS PBM risk corridors, FTC non-compete bans, and AI-driven prior authorization overrides marks the definitive end of the legacy he...
Read Full Story →
Medical ResearchThe 2026 FDA approval of an in vivo CRISPR therapy for Sanfilippo syndrome marks a historic shift in...
HealthcareThe simultaneous CMS GLP-1 mandate, the DOJ antitrust suit against HCA-Tenet, FDA AI wearable cleara...
Healthcare PolicyThe simultaneous CMS Medicare Advantage risk overhaul, the FTC/DOJ PBM probe, the 340B expansion, th...
Nutrition & FitnessThe FDA's OTC triple-agonist approval, the WHO's microplastic sarcopenia report, the Peloton-Tonal b...
Public HealthThe FDA's OTC CGM approval, the CDC's Bio-Sentinel network, and the WHO's mpox Clade Ib declaration ...
Public HealthThe convergence of H5N1 surveillance, GLP-1 actuarial shocks, and municipal wastewater sequencing ma...
